GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » Piotroski F-Score

Surgery Partners (Surgery Partners) Piotroski F-Score : 6 (As of May. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Surgery Partners has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Surgery Partners's Piotroski F-Score or its related term are showing as below:

SGRY' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 7
Current: 6

During the past 12 years, the highest Piotroski F-Score of Surgery Partners was 7. The lowest was 2. And the median was 5.


Surgery Partners Piotroski F-Score Historical Data

The historical data trend for Surgery Partners's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgery Partners Piotroski F-Score Chart

Surgery Partners Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 7.00 7.00 5.00

Surgery Partners Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 6.00 5.00 6.00

Competitive Comparison of Surgery Partners's Piotroski F-Score

For the Medical Care Facilities subindustry, Surgery Partners's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgery Partners's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Surgery Partners's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 18.9 + -4.9 + -1 + -12.4 = $1 Mil.
Cash Flow from Operations was 52.1 + 104.6 + 62.6 + 40.7 = $260 Mil.
Revenue was 667.6 + 674.1 + 735.4 + 717.4 = $2,795 Mil.
Gross Profit was 154.1 + 165.8 + 193.6 + 155.3 = $669 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(6643.3 + 6620.6 + 6780.1 + 6876.7 + 6975.6) / 5 = $6779.26 Mil.
Total Assets at the begining of this year (Mar23) was $6,643 Mil.
Long-Term Debt & Capital Lease Obligation was $3,044 Mil.
Total Current Assets was $896 Mil.
Total Current Liabilities was $523 Mil.
Net Income was -18.4 + -25 + -23.4 + -24.9 = $-92 Mil.

Revenue was 615.4 + 620.6 + 707.1 + 666.2 = $2,609 Mil.
Gross Profit was 134.6 + 131.2 + 184.3 + 134 = $584 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(6289.5 + 6291.6 + 6536.5 + 6682.1 + 6643.3) / 5 = $6488.6 Mil.
Total Assets at the begining of last year (Mar22) was $6,290 Mil.
Long-Term Debt & Capital Lease Obligation was $2,800 Mil.
Total Current Assets was $869 Mil.
Total Current Liabilities was $475 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Surgery Partners's current Net Income (TTM) was 1. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Surgery Partners's current Cash Flow from Operations (TTM) was 260. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=0.6/6643.3
=9.032E-5

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-91.7/6289.5
=-0.01457986

Surgery Partners's return on assets of this year was 9.032E-5. Surgery Partners's return on assets of last year was -0.01457986. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Surgery Partners's current Net Income (TTM) was 1. Surgery Partners's current Cash Flow from Operations (TTM) was 260. ==> 260 > 1 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=3044.3/6779.26
=0.44906081

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=2799.7/6488.6
=0.43147983

Surgery Partners's gearing of this year was 0.44906081. Surgery Partners's gearing of last year was 0.43147983. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=895.9/523.4
=1.71169278

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=868.9/475.1
=1.82887813

Surgery Partners's current ratio of this year was 1.71169278. Surgery Partners's current ratio of last year was 1.82887813. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Surgery Partners's number of shares in issue this year was 125.972. Surgery Partners's number of shares in issue last year was 125.206. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=668.8/2794.5
=0.23932725

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=584.1/2609.3
=0.22385314

Surgery Partners's gross margin of this year was 0.23932725. Surgery Partners's gross margin of last year was 0.22385314. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=2794.5/6643.3
=0.42064938

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=2609.3/6289.5
=0.41486605

Surgery Partners's asset turnover of this year was 0.42064938. Surgery Partners's asset turnover of last year was 0.41486605. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Surgery Partners has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Surgery Partners  (NAS:SGRY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Surgery Partners Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Surgery Partners's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgery Partners (Surgery Partners) Business Description

Traded in Other Exchanges
N/A
Address
340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027
Surgery Partners Inc is one of the few remaining independent ambulatory surgery center operators in the U.S. with national scale. The firm operates surgical facilities in approximately 30 states in partnership with physician groups and larger local healthcare systems. While surgical procedures drive a majority of the firm's revenue, the company also operates a clinical lab, urgent care facilities, and a handful of physician practices to provide additional healthcare services within the communities it serves. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Executives
Bain Capital Investors Llc director, 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt director, officer: Chief Executive Officer 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
T. Devin O'reilly director, 10 percent owner C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix director, 10 percent owner
Andrew T. Kaplan director C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Jason Eric Evans officer: EVP & Chief Operating Officer 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane officer: American Group President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
David T Doherty officer: Chief Financial Officer 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bradley R. Owens officer: National Group President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Danielle Burkhalter officer: Chief Human Resources Officer 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo officer: President, Atlantic Group 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock officer: Sr. VP, Gen Couns. & Sec. 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham officer: Chief Strategy Officer 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bain Capital Fund Xi, L.p. director, 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Xi, L.p. director, 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116